TKPHF - Takeda Pharmaceutical Non-GAAP EPS of ¥279.00, revenue of ¥2219.5B; updates FY outlook
2025-10-30 03:17:02 ET
More on Takeda Pharmaceutical
- Takeda Pharmaceutical Company Limited (TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules Transcript
- Takeda Pharmaceutical Company Limited (TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules - Slideshow
- Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually
- Innovent inks $11.4 billion cancer drug partnership with Japan's Takeda
- Trump’s 100% drug tariffs send pharma stocks lower